EUVIMEDEUVIMED entdecken
Crossref

Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway

Lu Yu, Hyun Ji Kim, Boram Kim, Hyung Jung Byun, Tuan Minh Nguyen, Eun Ji Kim, Hiu Huy Phùng, Ye Hyeon Kim, Mostafizur Rahman, Ji Yun Jang, Seung Bae Rho, Gyeoung Jin Kang und 5 weitere

Biochemical Pharmacology · 2023

DOI: 10.1016/j.bcp.2023.115537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023. Verfasst von Lu Yu und 16 weiteren Autor:innen. Beteiligte Einrichtung: BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 04620, Korea. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Ministry of Education, Ministry of Health and Welfare, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is characterized by high incidence and mortality. 90% of cancer deaths are caused by metastases. The epithelial-mesenchymal transition (EMT) process in cancer cells is a prerequisite for the metastatic process. Ethacrynic acid (ECA) is a loop diuretic that inhibits the EMT process in lung cancer cells. EMT has been related to the tumour immunemicroenvironment. However, the effect of ECA on immune checkpoint molecules in the context of cancer has not been fully identified. In the present study, we found that sphingosylphosphorylcholine (SPC) and TGF-β1, awell-known EMT inducer, induced the expression of B7-H4 in lung cancer cells. We also investigated the involvement of B7-H4 in the SPC-induced EMT process. Knockdown of B7-H4 suppressed SPC-induced EMT, while B7-H4 overexpression enhanced EMT of lung cancer cells. ECA inhibited SPC/TGF-β1-induced B7-H4 expression via suppression of STAT3 activation. Moreover, ECA inhibits the colonization of mice lung by tail vein-injected LLC1 cells. ECA-treated mice increased the CD4-positive T cells in lung tumour tissues. In summary, these results suggested that ECA inhibits B7-H4 expression via STAT3 inhibition, leading to SPC/TGF-β1-induced EMT. Therefore, ECA might be an immune oncological drug for B7-H4-positive cancer, especially lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsAnimalsMiceTransforming Growth Factor beta1Ethacrynic AcidEpithelial-Mesenchymal TransitionCell Line, TumorCell Movement

Stichwörter der Autor:innen

B7-H4Epithelial-mesenchymal transitionEthacrynic acidLun cancerSTAT3

Substanzen

Transforming Growth Factor beta1Ethacrynic Acid

Autor:innen und Institutionen

  • BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 04620, Korea.
  • Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.
  • BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 04620, Korea; National Cancer Center, Goyang 10408, Korea.
  • National Cancer Center, Goyang 10408, Korea.
  • BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 04620, Korea; National Cancer Center, Goyang 10408, Korea. Electronic address: mkpark@ncc.re.kr.
  • BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 04620, Korea. Electronic address: uatheone@dongguk.edu.

Förderung

  • Ministry of Education
  • Ministry of Health and Welfare
  • Korea Health Industry Development Institute
  • National Research Foundation of Korea

Zitieren

APA

Yu, L., Ji Kim, H., Kim, B., Jung Byun, H., Minh Nguyen, T., Ji Kim, E., Huy Phùng, H., Hyeon Kim, Y., Rahman, M., Yun Jang, J., Bae Rho, S., Jin Kang, G., Lee, H., Lee, K., Kyung Han, H., Kyung Park, M., & Hoon Lee, C. (2023). Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2023.115537

Vancouver

Yu L, Ji Kim H, Kim B, Jung Byun H, Minh Nguyen T, Ji Kim E, et al. Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway. Biochemical Pharmacology. 2023. doi:10.1016/j.bcp.2023.115537

BibTeX
@article{Yu2023,
  author = {Yu, Lu and Ji Kim, Hyun and Kim, Boram and Jung Byun, Hyung and Minh Nguyen, Tuan and Ji Kim, Eun and Huy Phùng, Hiu and Hyeon Kim, Ye and Rahman, Mostafizur and Yun Jang, Ji and Bae Rho, Seung and Jin Kang, Gyeoung and Lee, Ho and Lee, Kyeong and Kyung Han, Hyo and Kyung Park, Mi and Hoon Lee, Chang},
  title = {Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway},
  journal = {Biochemical Pharmacology},
  year = {2023},
  doi = {10.1016/j.bcp.2023.115537}
}
Kostenlos starten →